Skip to main content
DVA
NYSE Life Sciences

DaVita Guides FY Adj EPS to $14.10-$15.20, Above Consensus

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$218
Mkt Cap
$14.637B
52W Low
$101
52W High
$247.49
52W Position info
116% above low
Off High info
12% below high
Rel. Volume info
2.8× avg
Market data snapshot near publication time

DVA has more than doubled off its 52-week low of $101 on elevated volume (2.8× avg).

Summary

DaVita issued full-year adjusted EPS guidance of $14.10 to $15.20, a range that sits above the current consensus estimate of $13.80. The outlook reflects confidence in continued operational momentum following a strong Q1 that saw raised guidance and heavy buybacks. The midpoint of $14.65 implies roughly 15% growth over the prior year, driven by volume gains and cost discipline in its core dialysis business. This follows the $500 million term loan refinancing in June, which improved the balance sheet. The stock has already rallied 22% year-to-date, so the bar for positive surprise was high — this guidance clears it.

At the time of this announcement, DVA was trading at $218.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Nov 10, 2026, 12:42 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $180.24
Real-time Price: $161.71 info
Change: -$18.53 (-10%) info
Market Cap: $10.177B info
DVA
Oct 29, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $180.00
Real-time Price: $161.71 info
Change: -$18.29 (-10%) info
Market Cap: $10.177B info
DVA
Oct 29, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $184.00
Real-time Price: $161.71 info
Change: -$22.29 (-12%) info
Market Cap: $10.177B info
DVA
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $193.31
Real-time Price: $161.71 info
Change: -$31.60 (-16%) info
Market Cap: $10.177B info
DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $161.71 info
Change: -$20.99 (-11%) info
Market Cap: $10.177B info